Tjeerd Barf

2.1k total citations
33 papers, 1.7k citations indexed

About

Tjeerd Barf is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, Tjeerd Barf has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Genetics and 8 papers in Organic Chemistry. Recurrent topics in Tjeerd Barf's work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Tjeerd Barf is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Tjeerd Barf collaborates with scholars based in Netherlands, Sweden and United States. Tjeerd Barf's co-authors include Allard Kaptein, Bas van de Kar, Håkan Wikström, Todd Covey, Michael Gulrajani, Victor W. Pike, Julie A. McCarron, L Rondahl, Lars Farde and J. Uppenberg and has published in prestigious journals such as Nature Communications, Blood and Cancer Research.

In The Last Decade

Tjeerd Barf

33 papers receiving 1.6k citations

Peers

Tjeerd Barf
Eric T. Whalley United Kingdom
Flora Tang United States
Raymond J. Vavrek United States
Lenka Munoz Australia
Mark E. Duggan United States
Rajappa S. Kenchappa United States
Daniel Palmer United States
Gina H. Lu United States
Chinh Bach United States
William D. Singer United States
Eric T. Whalley United Kingdom
Tjeerd Barf
Citations per year, relative to Tjeerd Barf Tjeerd Barf (= 1×) peers Eric T. Whalley

Countries citing papers authored by Tjeerd Barf

Since Specialization
Citations

This map shows the geographic impact of Tjeerd Barf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tjeerd Barf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tjeerd Barf more than expected).

Fields of papers citing papers by Tjeerd Barf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tjeerd Barf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tjeerd Barf. The network helps show where Tjeerd Barf may publish in the future.

Co-authorship network of co-authors of Tjeerd Barf

This figure shows the co-authorship network connecting the top 25 collaborators of Tjeerd Barf. A scholar is included among the top collaborators of Tjeerd Barf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tjeerd Barf. Tjeerd Barf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Podoll, Terry, Paul G. Pearson, Allard Kaptein, et al.. (2022). Identification and Characterization of ACP-5862, the Major Circulating Active Metabolite of Acalabrutinib: Both Are Potent and Selective Covalent Bruton Tyrosine Kinase Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 384(1). 173–186. 15 indexed citations
2.
Demont, Dennis, et al.. (2021). Discovery and optimization of covalent EGFR T790M/L858R mutant inhibitors. Bioorganic & Medicinal Chemistry Letters. 52. 128406–128406. 2 indexed citations
3.
Bruin, Gerjan de, Dennis Demont, Edwin de Zwart, et al.. (2020). Discovery of quinoline-based irreversible BTK inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(14). 127261–127261. 7 indexed citations
4.
Wel, Tom van der, Riet Hilhorst, Hans den Dulk, et al.. (2020). Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis. Nature Communications. 11(1). 3216–3216. 9 indexed citations
5.
Kaptein, Allard, Gerjan de Bruin, Bas van de Kar, et al.. (2018). Potency and Selectivity of BTK Inhibitors in Clinical Development for B-Cell Malignancies. Blood. 132(Supplement 1). 1871–1871. 71 indexed citations
6.
Barf, Tjeerd, Todd Covey, Raquel Izumi, et al.. (2017). Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile. Journal of Pharmacology and Experimental Therapeutics. 363(2). 240–252. 272 indexed citations
7.
Barf, Tjeerd, Allard Kaptein, Dennis Demont, et al.. (2011). Structure-based lead identification of ATP-competitive MK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(12). 3818–3822. 19 indexed citations
8.
Oubrie, Arthur, Allard Kaptein, Edwin de Zwart, et al.. (2011). Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. Bioorganic & Medicinal Chemistry Letters. 22(1). 613–618. 13 indexed citations
9.
Kaptein, Allard, Arthur Oubrie, Edwin de Zwart, et al.. (2011). Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(12). 3823–3827. 17 indexed citations
10.
Klüter, Sabine, Jeffrey R. Simard, Haridas B. Rode, et al.. (2010). Characterization of Irreversible Kinase Inhibitors by Directly Detecting Covalent Bond Formation: A Tool for Dissecting Kinase Drug Resistance. ChemBioChem. 11(18). 2557–2566. 38 indexed citations
11.
Barf, Tjeerd, Fredrik Lehmann, Kristin Hammer, et al.. (2009). N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(6). 1745–1748. 96 indexed citations
12.
Hult, Malin, N. Shafqat, Björn Elleby, et al.. (2006). Active site variability of type 1 11β-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons. Molecular and Cellular Endocrinology. 248(1-2). 26–33. 33 indexed citations
13.
Barf, Tjeerd & Meredith Williams. (2006). Recent progress in 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-HSD1) inhibitor development. Drugs of the Future. 31(3). 231–231. 13 indexed citations
14.
Barf, Tjeerd. (2004). Intervention of Hepatic Glucose Production. Small Molecule Regulators of Potential Targets for Type 2 Diabetes Therapy. Mini-Reviews in Medicinal Chemistry. 4(8). 897–908. 25 indexed citations
15.
Lehmann, Fredrik, Eva Axén, J. Uppenberg, et al.. (2004). Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorganic & Medicinal Chemistry Letters. 14(17). 4445–4448. 71 indexed citations
16.
Hall, Håkan, Camilla Lundkvist, Christer Halldin, et al.. (1997). Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635. Brain Research. 745(1-2). 96–108. 240 indexed citations
17.
Saxena, Pramod R., Peter de Vries, Jan P.C. Heiligers, et al.. (1996). Investigations with GMC2021 in experimental models predictive of antimigraine activity and coronary side-effect potential. European Journal of Pharmacology. 312(1). 53–62. 8 indexed citations
18.
19.
Barf, Tjeerd, S. Mechiel Korte, G.A.H. Korte-Bouws, et al.. (1996). Potential anxiolytic properties of R-(+)-8-OSO2CF3-PAT, a 5-HT1A receptor agonist. European Journal of Pharmacology. 297(3). 205–211. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric T. Whalley Breakdown of academic impact, for papers by Flora Tang Breakdown of academic impact, for papers by Raymond J. Vavrek Breakdown of academic impact, for papers by Lenka Munoz Breakdown of academic impact, for papers by Mark E. Duggan Breakdown of academic impact, for papers by Rajappa S. Kenchappa Breakdown of academic impact, for papers by Daniel Palmer Breakdown of academic impact, for papers by Gina H. Lu Breakdown of academic impact, for papers by Chinh Bach Breakdown of academic impact, for papers by William D. Singer
Rankless by CCL
2026